Exenatide Treatment Causes Suppression of Serum Ghrelin Levels following Mixed Meal Test in Obese Diabetic Women
Aim. To investigate the effect of exenatide treatment on serum ghrelin levels in obese female patients with type 2 diabetes mellitus. Methods. Fourteen female patients with type 2 diabetes mellitus being treated with metformin and exenatide were enrolled. A mixed meal test was applied to the patient...
Saved in:
Main Authors: | Figen Topyildiz, Sinem Kiyici, Zulfiye Gul, Deniz Sigirli, Metin Guclu, Gurcan Kisakol, Sinan Cavun |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2016/1309502 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comment on “Metabolic Changes and Serum Ghrelin Level in Patients with Psoriasis”
by: Mehmet Agilli, et al.
Published: (2015-01-01) -
Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance
by: Xuan Du, et al.
Published: (2018-01-01) -
Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients
by: Jingwen Gan, et al.
Published: (2023-01-01) -
Recent Advances in Potential Clinical Application of Ghrelin in Obesity
by: Christine Delporte
Published: (2012-01-01) -
Structure and Physiological Actions of Ghrelin
by: Christine Delporte
Published: (2013-01-01)